Pathstone Family Office’s ICU Medical ICUI Stock Holding History

Pathstone Family Office’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$551K	Buy	4,632 +16	+0.3%	+$2.39K	﹤0.01%	997
2023 Q2	$824K	Hold	4,616	–	–	0.01%	548
2023 Q1	$761K	Sell	4,616 -5,460	-54%	-$939K	0.01%	527
2022 Q4	$1.54M	Buy	10,076 +883	+10%	+$134K	0.01%	583
2022 Q3	$1.39M	Buy	9,193 +6,026	+190%	+$1M	0.01%	586
2022 Q2	$521K	Buy	3,167 +267	+9%	+$51.4K	0.01%	557
2022 Q1	$713K	Buy	2,900 +199	+7%	+$44.6K	0.02%	425
2021 Q4	$641K	Buy	2,701 +101	+4%	+$23.6K	0.02%	460
2021 Q3	$607K	Buy	2,600 +700	+37%	+$147K	0.02%	450
2021 Q2	$391K	Buy	+1,900	New	+$391K	0.01%	560
2019 Q2	–	Sell	-8	Closed	-$2K	–	756
2019 Q1	$2K	Buy	+8	New	+$1.92K	﹤0.01%	770

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Pathstone Family Office's ICUI Position: Q3 2023 in Review

Pathstone Family Office increased its ICU Medical (ICUI) stake by 0.35% in Q3 2023, buying an estimated $2.39K and bringing the position to 4,632 shares worth $551K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Pathstone Family Office first reported a position in ICUI in Q1 2019 and has held it in 11 quarters since. The position peaked at $1.54M in Q4 2022. 220 funds tracked by Wall St. Rank hold ICUI as of Q3 2023.

Pathstone Family Office held 4,632 shares of ICU Medical worth $551K as of Q3 2023.
Pathstone Family Office bought 16 ICU Medical shares in Q3 2023, an estimated $2.39K.
ICU Medical made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #997 holding.
Pathstone Family Office first reported a position in ICU Medical in Q1 2019 and has held it in 11 quarters since.
Pathstone Family Office's ICU Medical position peaked at $1.54M in Q4 2022.
220 funds tracked by Wall St. Rank held ICU Medical as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.